A REVIEW OF OPPORTUNITY COST DEFINE

Understanding OUR Cytokine-Based Immunotherapy Candidates Our commitment extends to advancing a robust portfolio of programs geared toward growing the horizons of cytokine-based immunotherapy, especially for cancers where remedy selections remain limited. Use the links below to learn more about our portfolio of cytokine-based immunotherapy candidat